Today, the Vector Institute announced the renewal of its collaboration with Roche through 2030, extending a connection that ...

Discusses FDA Approval of KRESLADI Gene Therapy for Severe Leukocyte Adhesion Deficiency Type 1 March 27, 2026 8:30 ...

Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, today announced a 30-minute oral presentation on TG4050, the ...

Full-year results and business updateTransgene Continues Progressto Reshape Early-Stage Cancer Treatmentthrough Individualized Neoantigen ...

Los Angeles County’s effort to suppress mosquitoes through sterile-male releases is facing funding uncertainty that could ...

Montero Mining and Exploration Ltd. (TSXV: MON) (OTC Pink: MXTRF) (FSE: ES0) ("Montero" or the "Company") is pleased to ...

New National Forecast Signals Expanding Vector-Borne Disease Risk for Dogs -- with Implications for Human Health and a 94%+ Accurate Early Warning System SALEM, Ore., March 23, 2026 /PRNewswire/ -- ...

The New York State Department of Agriculture and Markets, in collaboration with the New York Farm Viability Institute (NYFVI) ...

Nadofaragene firadenovec-vncg is the only FDA-approved nonreplicating intravesical gene therapy for high-risk ...

Accelerated water-bath thawing, completed in about 25 minutes, may help streamline clinical workflows and support efficient patient management -- Label update includes data showing that product ...

Rare medical events draw intense attention during any mass vaccination campaign. Among COVID vaccine side effects, few ...

Legal observers warn that FinCEN retains broad authority over real estate transactions — and could ultimately impose stricter ...